New dawn in TB prevention therapy
After decades of relying on isoniazid-based TB preventive therapy as the best option for TB prevention, a number of new regimens have done well in clinical trials and at least some of them will soon be rolled out.
UNAIDS denies shut-down discussions, but refuses to answer specific questions
Spotlight published an opinion piece this week with leaked information about UNAIDS Executive Director Michel Sidibe’s correspondence with McKinsey and Company and senior UN leaders. The piece by AIDS-Free World…
AIDS2018: WHO recommends dolutegravir widely but women’s access will depend on contraception provision
WHO launched new interim guidance on HIV treatment at AIDS 2018 recommending dolutegravir (DTG) for everyone aged six years and above. [1, 2] But access to DTG for women and adolescent…
AIDS2018: What has happened to AIDS activism? Views from eight leading activists
There is a perception that AIDS activism is largely dead, that the AIDS activists have “retired”. There is a narrative and belief among some that there is a serious and…
AIDS2018: The future of AIDS activism: If we don’t join the dots we are dead
For over 30 years activism has been the engine that has driven almost every advance in our response to the AIDS epidemic. Mark Heywood assesses the state of activism in…
AIDS2018: UNAIDS LEAKS! Will Amsterdam Be UNAIDS’ Last Stand?
According to leaked information about UNAIDS Executive Director Michel Sidibe's correspondence with McKinsey and Company, 2018 will mark the beginning of the end of UNAIDS: the embattled leader has hatched…
AIDS2018: Is cancer the new AIDS?
By Ellen 't Hoen As the world gathers in Amsterdam for the 22nd International AIDS Conference, high medicines prices are again making headlines across the world. Ellen 't Hoen takes…
AIDS2018: Why the conference still matters at this point in the HIV Epidemic
There are many reasons why the end of the AIDS epidemic is not yet in sight and why the International AIDS Conference still matters, writes IAS President Linda-Gail Bekker. The…
New estimates of SA’s progress toward 90-90-90
The 90-90-90 targets have become key indicators against which to measure our progress in the HIV response. A new Human Sciences Research Council survey provides some estimates of how we are doing.
NHI Bill: Welcome but flawed
The People’s Health Movement South Africa (PHm-SA) are supportive of the principles that underpin the NHI, but they have several reservations about whether the NHI Bill can deliver universal health coverage. David Sanders & Louis Reynolds of PHM-SA explains.
The numbers: HIV and TB in South Africa
What are the key numbers regarding the HIV and TB epidemics in South Africa? We have published a new page on our website where we will keep track of all the latest estimates from a variety of sources.
NHI: It’s not just about the money
By Kerry Cullinan While the public health system is desperately under-funded, money alone will not fix it. Yet this is the underlying assumption of the National Health Insurance (NHI) Bill,…